Combined Transcranial Magnetic Stimulation and Therapy for MTBI Related Headaches
Key facts
- Who runs it
- Veterans Medical Research Foundation
- Where
- San Diego, United StatesSee the site
- Trial code
- Status
- Recruiting
- People taking part
- 240 people, planned
- Started
- 1 Jan 2022
- Planned end
- 31 Aug 2025
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Active rTMS
- Headache Management Therapy
- Sham rTMS
- Headache Education Control
- Record updated
- 21 November 2024
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Mild Traumatic Brain Injury (mTBI)
- Chronic headaches > 3 months after injury
- Aged 18-65
- No prior TMS treatment
- Persistent Headaches with an intensity > 30 / 100
- No history of daily headache prior to mTBI
Who cannot take part
- History of chronic headache like migraine prior to mTBI
- Evidence in chart of exacerbation of depressive/anxiety symptoms, active substance dependence, suicidal intent or attempt within previous month
- History of dementia or major psychiatric disease, such as bipolar disorder or schizophrenia
- History of seizure
- Pregnant
- Pacemaker or any metal in body that would prevent MRI
- Presence of any other chronic neuropathic pain states
- Pending litigation
- Can't understand English
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
This trial is currently available in United States.
- VA San Diego Healthcare SystemSan Diego, United StatesContact: Caleb Lopez, BSTaking people
About the trial
What the trial wants to find out
This study will assess the combined effectiveness of repetitive transcranial magnetic stimulation (rTMS) and telehealth based therapy in helping manage mild traumatic brain injury (mTBI) related headaches. The investigators hypothesize that active rTMS combined with telehealth therapy will provide marked reduction in mTBI related headaches and symptoms in comparison to their placebo counterparts.
The 4 groups in the trial
- Active rTMS with telehealth headache management therapyExisting treatment, for comparison
Participants receive both active rTMS treatment at the left dorsolateral prefrontal cortex and therapy for headache management
Treatment: Active rTMS and Headache Management Therapy
- Active rTMS with telehealth headache education controlOther group
Participants receive active rTMS treatment at the left dorsolateral prefrontal cortex and headache education
Treatment: Active rTMS and Headache Education Control
- Sham rTMS with telehealth headache management therapyOther group
Participants receive sham rTMS treatment at the left dorsolateral prefrontal cortex and therapy for headache management
Treatment: Headache Management Therapy and Sham rTMS
- Sham rTMS with telehealth headache education controlSham treatment, for comparison
Participants receive sham rTMS treatment at the left dorsolateral prefrontal cortex and headache education
Treatment: Sham rTMS and Headache Education Control
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Combined Nonpharmacological Therapies for MTBI-Related Headaches
- Criteria questions
- Built from NCT05176392, who can take part
- Record updated
- 21 November 2024